|
Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy Clinical Trials Information presented on Clinical Trials Search is not intended to be a substitute for qualified health advice, trips or treatment by using a genuine doctor. We aren't doctors. Always consult your mD on Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy Clinical research trials and Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy health trials take place in a lot of of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / projects is to answer specific human medical questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, like Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy. Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy Clinical Trials and other clinical trials allow for volunteers to have health treatment alternatives before they are available to the general public. Many times the test subjects obtain treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy clinical trial. Subjects oftentimes recieve the most effective healthcare possible for their Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy condition. Hazards are a reality, however, and could include additional or frequent doctor visits, healthcare dangers (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy  Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy
Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy
For Condition: HIV Infections,Pain,Peripheral Nervous System Diseases
Status: Recruiting
Sponsor(s): NeurogesX ,
Synopsis: The purpose of the study is to determine if an investigational drug, NGX-4010 (high-concentration capsaicin patch), is effective in treating painful HIV-associated neuropathy.
Details: The C107 study is a randomized, double-blind, controlled dose finding study of NGX-4010 for the treatment of painful symptoms of HIV-associated neuropathy. Participants will be randomly assigned to receive initial treatment according to one of three doses (application durations), and to receive double-blind NGX-4010 patch (high-concentration capsaicin) or matching control (low-concentration capsaicin). Participants who complete study evaluations through Week 12 will have the option of receiving up to 3 additional open-label treatments.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Dose Comparison, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Key Eligibility Criteria: • Must have had HIV-associated neuropathy for at least 2 months, with moderate to severe pain in both feet. • Must not have significant pain in feet due to other causes (for example, arthritis). • Must have intact skin at the treatment area. • Must be prepared to remain on the same pain medications at the same doses as before the study for the entire duration of the study (one year). • Must not use topical pain medications for HIV-associated neuropathy. • Must be able to comply with study requirements such as completing daily pain diary and attending study visits and refrain from extensive travel during study participation. • Must be at least 18 years old, not pregnant, and able to take care of self independently, with only occasional assistance if needed. • No significant medical problems of the heart, kidneys, liver or lungs, or cancer. • No history or current problem with substance abuse.
Total Enrollment: 300
Location and Contact Information:
Neurology Clinical Research *Recruiting*
Plantation, Florida, 33324
United States
Recruiting Francisco Torres 954-475-8171
East Bay AIDS Center *Recruiting*
Berkeley, California, 94705
United States
Recruiting Jamie Mandelke 510-204-1291
Park Nicollet Health Clinic *Recruiting*
Minneapolis, Minnesota, 55416
United States
Recruiting Meaghan Morton 952-993-2066
Community Research Initiative of New England *Recruiting*
Boston, Massachusetts, 02215
United States
Recruiting Karlissa Foy 617-778-5454
Steinhart Medical Center *Recruiting*
Miami, Florida, 33133
United States
Recruiting Amy Leibmann 305-856-2171
University of Kentucky *Recruiting*
Lexington, Kentucky, 40536
United States
Recruiting Yunanan Mootoor 859-323-6702
Body Positive *Recruiting*
Phoenix, Arizona, 85006
United States
Recruiting Gilda Garza 602-307-5330
University of North Carolina at Chapel Hill *Recruiting*
Chapel Hill, North Carolina, 27599
United States
Recruiting Wendy Robertson 919-966-6727
Stanford University Medical Center *Recruiting*
Stanford, California, 94305
United States
Recruiting Alexandria Luc 650-724-3792
University of Miami School of Medicine *Recruiting*
Miami, Florida, 33136
United States
Recruiting Leslie Thompson 305-243-3838
Central Texas Clinical Research *Recruiting*
Austin, Texas, 78705
United States
Recruiting Corey King 512-480-9660
Mount Sinai School of Medicine, Department of Neurology *Recruiting*
New York City, New York, 10029
United States
Recruiting Mary George 212-241-0784
First Clinical Research *Recruiting*
San Francisco, California, 94117
United States
Recruiting Lonnie Leonard 415-682-2434
AIDS Research Alliance *Recruiting*
West Hollywood, California, 90069
United States
Recruiting Michele Vertucci 310-358-2429
Albany Medical Center *Recruiting*
Albany, New York, 12208
United States
Recruiting Cynthia Morvillo 518-262-6970
University of Wisconsin *Recruiting*
Madison, Wisconsin, 53792-5132
United States
Recruiting Joanne Lubich 608-263-4290
HACRP - University of Hawaii *Recruiting*
Honolulu, Hawaii, 96816
United States
Recruiting Nancy Hanks 808-441-1531
The Cooper Health System *Recruiting*
Camden, New Jersey, 08103-1489
United States
Recruiting Alex Marr 856-968-7331
Case Western Reserve *Recruiting*
Cleveland, Ohio, 44106
United States
Recruiting Ron Johnson 216-844-3246
Community Research Initiative of New England *Recruiting*
Springfield, Massachusetts, 01107
United States
Recruiting Laurie Wojtusik 413-734-2264
Cook County Hospital, Dept. of Neurological Sciences *Recruiting*
Chicago, Illinois, 60612
United States
Recruiting Eileen Simeone 312-572-4578
University of California, San Diego *Recruiting*
San Diego, California, 92103
United States
Recruiting Will Toperoff 619-543-4734
Johns Hopkins University *Recruiting*
Baltimore, Maryland, 21205
United States
Recruiting Kathryn Carter 410-955-1895
Integra Clinical Research, LLC *Recruiting*
San Antonio, Texas, 78229
United States
Recruiting Cathy Kirkland 210-692-9249
The Research and Education Group *Recruiting*
Portland, Oregon, 97209
United States
Recruiting Erin Merrifield 503-229-8428
Wayne State University *Recruiting*
Detroit, Michigan, 48201
United States
Recruiting Kelly Jia 313-966-9407
IDC Research Initiative *Recruiting*
Altamonte Springs, Florida, 32071
United States
Recruiting Charmaine Stiles 407-647-3960
Treasure Coast Infectious Disease Consultants *Recruiting*
Vero Beach, Florida, 32960
United States
Recruiting Jeff Mieres 772-978-9556
New York Presbyterian Hospital *Recruiting*
New York City, New York, 10021
United States
Recruiting Ivanka Zaprlanov 212-746-2349
Arizona Clinical Research *Recruiting*
Phoenix, Arizona, 85023
United States
Recruiting Dawn Allen 602-863-6363
Washington University School of Medicine *Recruiting*
St. Louis, Missouri, 63108
United States
Recruiting Mary Gould 314-362-9733
North Dallas Center for AIDS & Clinical Research *Recruiting*
Dallas, Texas, 75208
United States
Recruiting John Gonzalez 214-941-4000
Infectious Disease of the Palm Beaches Associates *Recruiting*
North, Florida, 33408
United States
Recruiting Dora Vasquez 561-630-1402
Additional Information:
Study ID Numbers: C107;
Study Start Date:
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00064623
Other Pain Studies:
1. Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
2. Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases
3. Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
4. A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain
5. Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of Postherpetic Neuralgia
Related Studies:
Other Pain Clinical Trials
Other New York Clinical Trials
Other Albany Clinical Trials
Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy
|
|
|
|
|
|
|
|
